Floatz logo

Sertraline

Major Depressive Disorder

First Affiliated Hospital of Chongqing Medical UniversitySmall moleculePhase 4 / ApprovedActive
BB
71/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
73/ 100
Competitive Position
65/ 100

Competitive context

197 Active assets in the Major Depressive Disorder cohort.

Asset / SponsorPhaseRating
Zelapar
Corium Innovations, Inc.
Phase 4BBB
Risperidone
Johns Hopkins University
Phase 4BBB
EDIVOXETINE
Eli Lilly and Company
Phase 3BBB
Vortioxetine
Mayo Clinic
Phase 4BBB
Brexpiprazole
Nova Scotia Health Authority
Phase 4BBB

View all 50 →

Same molecule, other indications

Sertraline is also rated in:

anxiety disorderActive
BBB
Indicative · Phase 4
76 / 100
View asset →
psychotic disorderActive
BBB
Indicative · Phase 4
74 / 100
View asset →
depressive disorderActive
BBB
Indicative · Phase 4
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →